Literature DB >> 14057349

SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES.

I TAMM, H J EGGERS.   

Abstract

Keywords:  BENZIMIDAZOLES; COXSACKIE VIRUSES; ECHO VIRUSES; EXPERIMENTAL LAB STUDY; GUANIDINES; PHARMACOLOGY; PICORNAVIRUS; POLIOVIRUS; RHINOVIRUS; RNA, VIRAL

Mesh：

Substances：

Year:  1963        PMID： 14057349     DOI： 10.1126/science.142.3588.24

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  23 in total

1.  Selective inhibition of the synthesis of single-stranded RNA of encephalomyocarditis virus by 2-(alpha-hydroxybenzyl)-benzimidazole in cell-free systems.

Authors:  T M Dmitrieva; V I Agol
Journal:  Arch Gesamte Virusforsch       Date:  1974

2.  [Antiviral activity of imidazole derivatives. I. Inhibition of multiplication of mengovirus in FL cells].

Authors:  M Tonew; E M Tonew
Journal:  Arch Gesamte Virusforsch       Date:  1971

3.  Antiviral action of gliotoxin.

Authors:  J K McDougall
Journal:  Arch Gesamte Virusforsch       Date:  1969

4.  Specific effect of guanidine in the programming of poliovirus inhibition of deoxyribonucleic acid synthesis.

Authors:  C D Powers; B A Miller; H Kurtz; W W Ackermann
Journal:  J Virol       Date:  1969-03       Impact factor: 5.103

5.  Effect of poliovirus on deoxyribonucleic acid synthesis in HeLa cells.

Authors:  W W Ackermann; D C Cox; H Kurtz; C D Powers; S J Davies
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

6.  The specific effectors of viral development.

Authors:  A Lwoff
Journal:  Biochem J       Date:  1965-08       Impact factor: 3.857

7.  On the nature of the cystine-dependent phenotype of poliovirus.

Authors:  V M Zaides; L B Elbert; S V Maslova; V I Agol
Journal:  Arch Gesamte Virusforsch       Date:  1968

8.  Antipicornavirus flavone Ro 09-0179.

Authors:  H Ishitsuka; C Ohsawa; T Ohiwa; I Umeda; Y Suhara
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

9.  Differences in multiplication of virulent and vaccine strains of poliovirus type I, II, and III in laboratory animals.

Authors:  G A Koroleva; V A Lashkevich; M K Voroshilova
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.